[1]
V., R. et al. 2014. EVALUATION OF CARDIO PROTECTIVE ACTIVITY OF GALANGIN AGAINST DOXORUBICIN INDUCED CARDIOMYOPATHY. International Journal of Pharmacy and Pharmaceutical Sciences. 6, 9 (Sep. 2014), 86–90.